Alpha-Ketoglutarate (AKG) Explained Simply

1. What It Is About

Alpha-ketoglutarate, or AKG for short, is an intermediate product in the metabolism of every cell. It forms when the body breaks down protein building blocks such as glutamate or glutamine, and it is important for energy production. AKG also occurs in small amounts in foods, for example in fermented dairy products or meat. For dietary supplements, it is usually bound to other substances, such as calcium or ornithine, because the pure acid is not stable. Ornithine is an amino acid, meaning it is a protein building block. Researchers are interested in AKG because it is involved in many steps of cellular metabolism. However, absorption through the gut is limited: some of it is converted there, and blood levels rise only briefly. For this reason, studies often measure indirect signs such as amino acid or hormone levels rather than direct effects. Research to date has focused heavily on basic science and animal experiments; controlled human studies are rare. The few clinical data come almost exclusively from burn medicine and ageing research.

2. What Studies Show

The most informative study is a controlled trial in severely burn-injured patients. They received ornithine alpha-ketoglutarate, a compound of ornithine and AKG. Wound healing time was markedly shortened compared with the control group. Antibiotic use and nutritional status also developed more favourably. The exact size of the effect was not stated in the paper’s abstract. The study was conducted at a single centre, a military hospital, and provided no detailed information on comorbidities or other medications. Whether the effect comes from the combination of ornithine and AKG or from one of the two substances alone was not examined. 1 1

A small controlled study in six healthy men examined how ornithine alpha-ketoglutarate, ornithine hydrochloride and calcium alpha-ketoglutarate affect amino acids and hormones in the blood. After calcium alpha-ketoglutarate, blood glutamate levels rose markedly after 60 minutes. Ornithine levels in the blood, by contrast, changed little. The observation period lasted only five hours, and the number of participants was very small. The study did not test AKG alone, so no conclusion can be drawn about the effect of AKG alone. 4

In ageing research there are first indications. One study tested whether older but healthy adults could be recruited for a planned placebo-controlled trial. A total of 120 participants aged 40 to 60 years were enrolled. They were to take delayed-release calcium alpha-ketoglutarate or a placebo for six months. Results on the effect on biological age have not yet been published. 2

Plausible An observational study found an association between taking a combination preparation of delayed-release calcium alpha-ketoglutarate and vitamins and an average 1.8 years lower biological age. This association remained after adjustment for age, sex, smoking and health status. However, the study did not examine AKG or the vitamins individually, and its design does not allow conclusions about cause and effect. The participants were also a selected group of health enthusiasts. 3

Plausible In animal experiments with mice that had type 2 diabetes, AKG for seven days reduced platelet and white blood cell activation and inflammatory mediators in the blood. Whether these effects occur in humans has not been investigated. 5

3. What Remains Unclear

Human studies are old, small or not designed to assess clinical endpoints. The burn study is the only controlled work with a clear clinical outcome, yet even there it is unclear whether the faster wound healing comes from AKG, from ornithine or from the additional nitrogen supply. The observational study on biological age cannot demonstrate an effect; it only shows an association in a selected group. For applications such as sport, immune modulation or neuroprotection, there are no controlled human studies. Dose-finding studies and long-term safety data are lacking. Gut absorption of AKG is low, and the different salts—ornithine AKG and calcium AKG—are not directly comparable. There are also no direct evidence on overdose or fixed upper limits. In a controlled study, ornithine alpha-ketoglutarate was described as safe and well tolerated, with no adverse effects reported; however, exact quantities were not specified. 1

4. What This Means in Everyday Life

Anyone interested in alpha-ketoglutarate will find some positive hints in the available studies, but no solid basis for general applications. The most striking results come from the treatment of severely burn-injured patients and from ageing research—both are special areas. For healthy people who wish to influence their performance or ageing, there are no controlled studies that demonstrate a benefit. In the studies examined, AKG preparations were well tolerated, but long-term safety data are missing. Anyone considering taking AKG should be aware that the evidence base is still developing and many questions remain open. The next step would be larger, controlled human studies to clarify whether AKG actually works in different applications and what dose is appropriate.

All details with study numbers and sources: detailed page on Alpha-Ketoglutarate (AKG). For children: Alpha-Ketoglutarate (AKG) for children.